Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Management of Slightly Elevated Fasting Blood Glucose After Ischemic Stroke

Rationale for Active Glucose Management

  • Hyperglycemia after ischemic stroke is independently associated with infarct expansion, hemorrhagic transformation, and poor neurological outcomes, making active glucose management essential even at 2 days post-stroke, according to the American Heart Association/American Stroke Association guidelines 1
  • The American Heart Association/American Stroke Association guidelines recommend treating elevated glucose concentrations in the range of 140-180 mg/dL 1

Treatment Algorithm

  • If fasting glucose exceeds 140 mg/dL, insulin therapy should be initiated with a target range of 140-180 mg/dL, as recommended by the American College of Cardiology 1
  • If fasting glucose exceeds 200 mg/dL, strong consideration should be given to insulin therapy per guideline consensus 1

Monitoring Requirements

  • Glucose should be monitored every 6 hours initially in the first 24-48 hours 1
  • Potassium levels should be checked before and during insulin therapy to avoid hypokalemia 1
  • Glucose levels <80 mg/dL should be avoided, as hypoglycemia may be more immediately dangerous than moderate hyperglycemia 1

Why Not the Other Options?

  • Warfarin is not indicated in this case, as the patient is already on antiplatelet therapy, which is the appropriate treatment for non-cardioembolic ischemic stroke, according to guidelines from the journal Stroke 2
  • Warfarin is reserved for patients with atrial fibrillation, cardioembolic stroke from valvular heart disease, or recent myocardial infarction, as stated in the International Journal of Stroke 3

Long-term Diabetes Management Considerations

  • Comprehensive diabetes management should follow national guidelines, with a goal for long-term management of HbA1c <7%, as recommended in the journal Circulation 4

Critical Pitfalls to Avoid

  • Active glucose management with insulin is strongly supported by evidence, rather than observation alone, with careful monitoring to avoid hypoglycemia and electrolyte disturbances 1
  • Persistent hyperglycemia (>200 mg/dL) during the first 24 hours independently predicts expansion of infarct volume and worse outcomes, emphasizing the importance of prompt insulin initiation 1
  • Targeting glucose levels <80 mg/dL should be avoided, as symptomatic hypoglycemia can occur, highlighting the need for careful glucose control 1